-
OxSonics
Created in 2013
-
-
Up & running (A)
Existing signals show a regular activity -
Social networks
2,429 73 -
Activities
-
Technologies
-
Entity types
-
Location
Magdalen Centre, 1 Robert Robinson Ave, Littlemore, Oxford OX4 4GA, UK
Oxford,
United Kingdom
-
Employees
Scale: 11-50
Estimated: 15
-
Engaged catalyst
4
0 0 -
Added in Motherbase
3 years, 4 months ago
-
Value proposition
Tackling the toughest cancers.
We’re OxSonics, a pioneering clinical-stage medical device company committed to developing a ground-breaking platform technology to deliver anti-cancer drugs so they can act smarter, act faster and, above all, work better.
Our SonoTran® Platform has been designed to actively enhance the delivery of oncology drugs into solid tumours. SonoTran® is drug agnostic and requires no drug reformulation enabling its use with both existing and novel therapies.
We have our own development programs as well as collaborations with Pharmaceutical and biotech companies to work to bring smarter, faster and better therapies to as many patient groups as possible.
Drug Delivery, Oncology, Medical Devices, and Immune Oncology
-
Home - OxSonics
https://oxsonics.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Amgen
Biotechnology, Biotechnology Research (Auto) |
Amgen
Biotechnology, Biotechnology Research (Auto) |
Other
2 Mar 2026 |
|
|
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
2 Mar 2026 |
|
|
Takeda
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Takeda
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
31 Jan 2024 |
|
|
Oxford University Innovation
Research, Investment Management (Auto) |
Oxford University Innovation
Research, Investment Management (Auto) |
Other
18 Jan 2025 |
|
|